Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Christine W Bruggeman"'
Autor:
Christine W Bruggeman, Julia Houtzager, Barbara Dierdorp, Jesper Kers, Steven T Pals, René Lutter, Thomas van Gulik, Joke M M den Haan, Timo K van den Berg, Robin van Bruggen, Taco W Kuijpers
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223264 (2019)
Recently it was discovered that tissue-resident macrophages derive from embryonic precursors, not only from peripheral blood monocytes, and maintain themselves by self-renewal. Most in-vitro studies on macrophage biology make use of in-vitro cultured
Externí odkaz:
https://doaj.org/article/cf1bab13de7c4340a36d1f723509c4f6
Publikováno v:
STAR Protocols, Vol 4, Iss 1, Pp 102121- (2023)
Summary: Here, we present a protocol to use microfluidics in combination with fluorescence microscopy to expose the C. elegans tail to chemosensory stimuli. We describe steps for the preparation of microfluidic chips and sample preparation through th
Externí odkaz:
https://doaj.org/article/e1ccc2a00f464d5984f0079ca1d4d374
Autor:
Sietse Q. Nagelkerke, Christine W. Bruggeman, Joke M.M. den Haan, Erik P.J. Mul, Timo K. van den Berg, Robin van Bruggen, Taco W. Kuijpers
Publikováno v:
Blood Advances, Vol 2, Iss 8, Pp 941-953 (2018)
Abstract: Tissue-resident macrophages in the spleen play a major role in the clearance of immunoglobulin G (IgG)–opsonized blood cells, as occurs in immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). Blood cells are phagocytosed
Externí odkaz:
https://doaj.org/article/21e0c97dd6d849309bd5608ffb0617aa
Autor:
Louise W. Treffers, Michel van Houdt, Christine W. Bruggeman, Marieke H. Heineke, Xi Wen Zhao, Joris van der Heijden, Sietse Q. Nagelkerke, Paul J. J. H. Verkuijlen, Judy Geissler, Suzanne Lissenberg-Thunnissen, Thomas Valerius, Matthias Peipp, Katka Franke, Robin van Bruggen, Taco W. Kuijpers, Marjolein van Egmond, Gestur Vidarsson, Hanke L. Matlung, Timo K. van den Berg
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
The function of the low-affinity IgG-receptor FcγRIIIb (CD16b), which is uniquely and abundantly expressed on human granulocytes, is not clear. Unlike the other Fcγ receptors (FcγR), it is a glycophosphatidyl inositol (GPI) -anchored molecule and
Externí odkaz:
https://doaj.org/article/4f7effa6b2a44b6cb973aba88e5a5277
Autor:
Christine W. Bruggeman, Gillian Dekkers, Remco Visser, Naneth W. M. Goes, Timo K. van den Berg, Theo Rispens, Gestur Vidarsson, Taco W. Kuijpers
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsoni
Externí odkaz:
https://doaj.org/article/cf4664692f7847888d590e42d87c040c
Autor:
Christine W. Bruggeman, Guus H. Haasnoot, Noémie Danné, Jaap van Krugten, Erwin J.G. Peterman
SummaryCilia are membrane-enveloped organelles that protrude from the surface of most eurokaryotic cells and play crucial roles in sensing the external environment. For maintenance and function cilia are dependent on intraflagellar transport (IFT). H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c0bf9d5523478c9924f908813fa1518
https://doi.org/10.1101/2022.04.28.489874
https://doi.org/10.1101/2022.04.28.489874
Autor:
Taco W. Kuijpers, Sietse Q. Nagelkerke, Cedric Manlhiot, Masja de Haas, Christine W. Bruggeman, Rae S. M. Yeung, Robin van Bruggen, Brian W. McCrindle, Wendy Lau
Publikováno v:
Blood Adv
Blood advances, 4(14), 3416-3426. American Society of Hematology
Blood advances, 4(14), 3416-3426. American Society of Hematology
Hemolytic anemia resulting from IV Immunoglobulin (IVIG) treatment can be a serious complication, especially for those with underlying conditions with a high level of inflammation and after administration of high IVIG dosages, such as Kawasaki diseas
Autor:
Arno van Heijst, Judy Geissler, Emile van den Akker, Michel van Houdt, Wouter Koole, Koen J. van Aerde, Han J.M.P. Verhagen, Ivo van der Bijl, Cathelijn E.M. Aarts, Gerald Jaspers, Christine W. Bruggeman, Anton T.J. Tool, Evelien G. G. Sprenkeler, Thatjana Gardeitchik, Floris P. J. van Alphen, Iris C. Kreft, Martin de Boer, Hans Janssen, Taco W. Kuijpers, Stefanie S. V. Henriet, Kian D. Liem, Paul Verkuijlen, Timo K. van den Berg, Simon Tol, Robin van Bruggen
Publikováno v:
Blood, 135(24), 2171-2181. American Society of Hematology
Blood, 135, 24, pp. 2171-2181
Blood, 135, 2171-2181
Blood
Blood, 135, 24, pp. 2171-2181
Blood, 135, 2171-2181
Blood
Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics, by coactivating serum response factor. Recently, the first human with MKL1 deficiency, leading to a novel primary immunodef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b809e6d92354a647f689ade8ce4f44
https://pure.amc.nl/en/publications/mkl1-deficiency-results-in-a-severe-neutrophil-motility-defect-due-to-impaired-actin-polymerization(8e622be7-3e65-412f-b3c2-5eedcabc6963).html
https://pure.amc.nl/en/publications/mkl1-deficiency-results-in-a-severe-neutrophil-motility-defect-due-to-impaired-actin-polymerization(8e622be7-3e65-412f-b3c2-5eedcabc6963).html
Autor:
Gillian Dekkers, Sietse Q. Nagelkerke, James C. Zimring, Peter C. Ligthart, Louise A. de Neef, Manfred Wuhrer, Jana Koers, Christine W. Bruggeman, Erik L. de Graaf, Theo Rispens, Taco W. Kuijpers, Gestur Vidarsson, A. Robin Temming, Steven W. de Taeye
Publikováno v:
Journal of Immunology, 203(12), 3126-3135
Journal of immunology (Baltimore, Md., 203(12), 3126-3135. American Association of Immunologists
Journal of immunology (Baltimore, Md., 203(12), 3126-3135. American Association of Immunologists
Ab-dependent cellular cytotoxicity (ADCC) is one of the most important effector mechanisms of tumor-targeting Abs in current immunotherapies. In ADCC and other Ab-dependent activation of myeloid effector cells, close cell–cell contact (between effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8530629ee5fb74a4d4b1897ff701ba8b
http://hdl.handle.net/1887/121321
http://hdl.handle.net/1887/121321
Autor:
Lani Lieberman, Beth Binnington, Nadine Shehata, Donald R. Branch, Emeralda Burke-Murphy, Jacob Pendergrast, Barbara Hannach, Katerina Pavenski, Vincent Laroche, Megan Blacquiere, Yulia Lin, Kezia Willie, Jiwajee Aziz, Jeannie Callum, Wendy Lau, Christine Cserti-Gazdewich, Jill R. Storry, Lorna Sampson Riden, Åsa Hellberg, Christine W. Bruggeman, Nagina Parmar, Darinka Sakac, Tik Nga Tong, Chantal Armali, Taco W. Kuijpers, Martin L. Olsson
Publikováno v:
Blood, 131(7), 830-835. American Society of Hematology
TO THE EDITOR: Although frequently effective[1][1],[2][2] and usually benign, high-dose (2 g/kg) intravenous immunoglobulin (IVIG) therapy can result in marked red blood cell (RBC) hemolysis, which in some cases is life threatening in severity.[3][3]